The FDA has specifically flagged risks including dosing errors, variable concentrations, improper storage during shipping, quality control differences, limited adverse-event reporting, and products falsely marketed for research or non-human-use purposes

Research has examined its role in: IGFBP-independent, sustained IGF-1R activation and downstream pathway modelling Myogenic satellite cell proliferation, myotube formation, and skeletal muscle biology PI3K/Akt/mTOR and MAPK/ERK signalling cascade investigations Human pluripotent stem cell (hPSC) and embryonic stem cell (ESC) maintenance culture Mesenchymal stem cell niche biology and self-renewal pathway studies Biopharmaceutical CHO cell culture supplementation and recombinant protein production models Glucose uptake and GLUT4 translocation research in adipocyte models Vascular smooth muscle cell biology and plaque stability research Neuroregeneration, neuron survival, and peripheral nerve research applications models Protein synthesis, cellular hypertrophy, and anti-apoptotic pathway research IGF-1 LR3 and Myogenic Research Animal studies investigate skeletal muscle tissue responses to IGF-1 LR3 administration, with laboratory models measuring satellite cell activation via proliferation markers such as Ki-67, myotube formation and differentiation in vitro, and fibre cross-sectional area changes in mouse models with research focusing on both hypertrophy and hyperplasia pathways

MK-677 demonstrates superior outcomes in elderly populations a 2008 study in hip fracture patients showed 25 mg daily improved gait speed and reduced falls by 30% over 12 months
The peptides are fragile molecules that degrade when exposed to heat, light, or bacterial contamination